IMGT Corporation Limited Logo

IMGT Corporation Limited

Develops a drug delivery platform using focused ultrasound and nanotechnology.

456570 | KO

Overview

Corporate Details

ISIN(s):
KR7456570001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 돌마로 172, 성남시

Description

IMGT Corporation Limited is a clinical-stage biotechnology company that develops a proprietary drug delivery platform for intractable diseases. The company's core technology integrates focused ultrasound with nanotechnology to create an image-guided therapy system. This platform is designed to enhance the targeted delivery of gene therapies, nanomedicines, and other therapeutic agents directly to diseased tissues. By leveraging the synergistic effects of ultrasound and nanoparticles, IMGT aims to improve treatment efficacy and precision, particularly in oncology. The company is actively advancing its solutions through clinical trials for applications such as pancreatic cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-31 00:00
대표이사변경
Korean 10.4 KB
2025-03-31 00:00
정기주주총회결과
Korean 26.4 KB
2025-03-20 00:00
기타주요경영사항(자율공시) (감사보고서 제출 지연)
Korean 4.9 KB
2025-03-20 00:00
사업보고서제출기한연장신고서 (2024.12)
Korean 8.5 KB
2025-03-14 00:00
주주총회소집공고
Korean 92.4 KB
2025-03-14 00:00
주주총회소집결의
Korean 16.3 KB
2024-12-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-12-05 00:00
주식등의대량보유상황보고서(약식)
Korean 82.9 KB
2024-12-05 00:00
[기재정정]주식등의대량보유상황보고서(약식)
Korean 87.1 KB
2024-11-07 00:00
특허권취득(자율공시) (접속 초음파 장치 및 영상 트랜스듀서 보호 방법)
Korean 7.0 KB
2024-10-30 00:00
기업설명회(IR)개최결과
Korean 6.6 KB
2024-10-14 00:00
기업설명회(IR)개최
Korean 6.9 KB
2024-09-25 00:00
임시주주총회결과
Korean 4.5 KB
2024-09-10 00:00
주주총회소집공고
Korean 57.0 KB

Automate Your Workflow. Get a real-time feed of all IMGT Corporation Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IMGT Corporation Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IMGT Corporation Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.